Cargando…

Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial

BACKGROUND: The ideal strategy to prime the cardiopulmonary bypass (CPB) circuit in adult cardiac surgery is still a matter of debate. OBJECTIVES: In this retrospective study, we examined Albumin solution and hydroxyethyl starch (HES) for priming the CPB circuit and evaluated the differences in kidn...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseinzadeh Maleki, Mahmood, Derakhshan, Pooya, Rahmanian Sharifabad, Amir, Amouzeshi, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834664/
https://www.ncbi.nlm.nih.gov/pubmed/27110527
http://dx.doi.org/10.5812/aapm.30326
_version_ 1782427522860843008
author Hosseinzadeh Maleki, Mahmood
Derakhshan, Pooya
Rahmanian Sharifabad, Amir
Amouzeshi, Ahmad
author_facet Hosseinzadeh Maleki, Mahmood
Derakhshan, Pooya
Rahmanian Sharifabad, Amir
Amouzeshi, Ahmad
author_sort Hosseinzadeh Maleki, Mahmood
collection PubMed
description BACKGROUND: The ideal strategy to prime the cardiopulmonary bypass (CPB) circuit in adult cardiac surgery is still a matter of debate. OBJECTIVES: In this retrospective study, we examined Albumin solution and hydroxyethyl starch (HES) for priming the CPB circuit and evaluated the differences in kidney function and bleeding and coagulation status in the two groups of patients. PATIENTS AND METHODS: Sixty consecutive patients undergoing elective coronary artery bypass grafting were studied. Patients were excluded due to emergency surgery, history of cardiac surgery, history of receiving medication with antiplatelet agents except ASA 80 (mg/day) within the previous five days, preoperative coagulation disorder, left ventricular ejection fraction less than 50%, preoperative renal dysfunction (serum creatinine > 1.4 mg/dL), preoperative hepatic dysfunction (serum aspartate/alanine amino transferase > 60 U/l), preoperative electrolyte imbalance, known hypersensitivity to HES and chronic diuretic therapy. The patients were divided randomly into two groups of HES (n = 30) and Albumin (n = 30). Hemodynamic parameters, serum creatinine concentrations and glomerular filtration rate, PT, PTT and INR were measured. Early bleeding was measured according to the first 24-hour drainage from the tube. Hemodynamics and all laboratory measurements were performed after induction of anesthesia and at the morning of the first, second and third postoperative days in the ICU. RESULTS: GFR differences were statistically lower in Albumin group in comparison with Group B at 24, 48 and 72 hours postoperation. Platelet count difference and postoperative bleeding were significantly lower in Albumin group. CONCLUSIONS: Administration of Albumin compared to HES in patients with a normal renal function results in a lower drop of GFR and platelet count, less bleeding and lower rise of serum creatinine.
format Online
Article
Text
id pubmed-4834664
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-48346642016-04-22 Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial Hosseinzadeh Maleki, Mahmood Derakhshan, Pooya Rahmanian Sharifabad, Amir Amouzeshi, Ahmad Anesth Pain Med Research Article BACKGROUND: The ideal strategy to prime the cardiopulmonary bypass (CPB) circuit in adult cardiac surgery is still a matter of debate. OBJECTIVES: In this retrospective study, we examined Albumin solution and hydroxyethyl starch (HES) for priming the CPB circuit and evaluated the differences in kidney function and bleeding and coagulation status in the two groups of patients. PATIENTS AND METHODS: Sixty consecutive patients undergoing elective coronary artery bypass grafting were studied. Patients were excluded due to emergency surgery, history of cardiac surgery, history of receiving medication with antiplatelet agents except ASA 80 (mg/day) within the previous five days, preoperative coagulation disorder, left ventricular ejection fraction less than 50%, preoperative renal dysfunction (serum creatinine > 1.4 mg/dL), preoperative hepatic dysfunction (serum aspartate/alanine amino transferase > 60 U/l), preoperative electrolyte imbalance, known hypersensitivity to HES and chronic diuretic therapy. The patients were divided randomly into two groups of HES (n = 30) and Albumin (n = 30). Hemodynamic parameters, serum creatinine concentrations and glomerular filtration rate, PT, PTT and INR were measured. Early bleeding was measured according to the first 24-hour drainage from the tube. Hemodynamics and all laboratory measurements were performed after induction of anesthesia and at the morning of the first, second and third postoperative days in the ICU. RESULTS: GFR differences were statistically lower in Albumin group in comparison with Group B at 24, 48 and 72 hours postoperation. Platelet count difference and postoperative bleeding were significantly lower in Albumin group. CONCLUSIONS: Administration of Albumin compared to HES in patients with a normal renal function results in a lower drop of GFR and platelet count, less bleeding and lower rise of serum creatinine. Kowsar 2016-01-18 /pmc/articles/PMC4834664/ /pubmed/27110527 http://dx.doi.org/10.5812/aapm.30326 Text en Copyright © 2016, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Hosseinzadeh Maleki, Mahmood
Derakhshan, Pooya
Rahmanian Sharifabad, Amir
Amouzeshi, Ahmad
Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial
title Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial
title_full Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial
title_fullStr Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial
title_full_unstemmed Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial
title_short Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 (Voluven) on Renal Function as Priming Solutions for Cardiopulmonary Bypass: A Randomized Double Blind Clinical Trial
title_sort comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 (voluven) on renal function as priming solutions for cardiopulmonary bypass: a randomized double blind clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834664/
https://www.ncbi.nlm.nih.gov/pubmed/27110527
http://dx.doi.org/10.5812/aapm.30326
work_keys_str_mv AT hosseinzadehmalekimahmood comparingtheeffectsof5albuminand6hydroxyethylstarch13004voluvenonrenalfunctionasprimingsolutionsforcardiopulmonarybypassarandomizeddoubleblindclinicaltrial
AT derakhshanpooya comparingtheeffectsof5albuminand6hydroxyethylstarch13004voluvenonrenalfunctionasprimingsolutionsforcardiopulmonarybypassarandomizeddoubleblindclinicaltrial
AT rahmaniansharifabadamir comparingtheeffectsof5albuminand6hydroxyethylstarch13004voluvenonrenalfunctionasprimingsolutionsforcardiopulmonarybypassarandomizeddoubleblindclinicaltrial
AT amouzeshiahmad comparingtheeffectsof5albuminand6hydroxyethylstarch13004voluvenonrenalfunctionasprimingsolutionsforcardiopulmonarybypassarandomizeddoubleblindclinicaltrial